INTERACTIONS BETWEEN 6-MERCAPTOPURINE THERAPY AND THIOPURINE-METHYL-TRANSFERASE (TPMT) ACTIVITY - REPLY

被引：0
|
作者：
CAPDEVILLE, R
MOUSSON, B
BAX, G
机构：
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1995年 / 48卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：87 / 88
页数：2
相关论文
共 50 条
  • [41] Thiopurine methyl-transferase activity influences clinical response to azathioprine therapy in patients with IBD
    Cuffari, C
    Maqbool, A
    Jones, L
    Bayless, TM
    GASTROENTEROLOGY, 2001, 120 (05) : A623 - A623
  • [42] TPMT polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemia
    Dreisig, Karin
    Brunner, Emilie Damgaard
    Marquart, Hanne V.
    Helt, Louise Rold
    Nersting, Jacob
    Frandsen, Thomas Leth
    Jonsson, Olafur Gisli
    Taskinen, Mervi
    Vaitkeviciene, Goda
    Lund, Bendik
    Abrahamsson, Jonas
    Lepik, Kristi
    Schmiegelow, Kjeld
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2021, 38 (03) : 227 - 238
  • [43] Interactions between PAMAM-NH2 and 6-Mercaptopurine: Qualitative and Quantitative NMR studies
    Gao, Xueke
    Ma, Minjun
    Pedersen, Christian Marcus
    Liu, Rui
    Zhang, Zhenzhou
    Chang, Honghong
    Qiao, Yan
    Wang, Yingxiong
    CHEMISTRY-AN ASIAN JOURNAL, 2021, 16 (22) : 3658 - 3663
  • [44] Comparison of 6-mercaptopurine with 6-thioguanine for the analysis of thiopurine S-methyltransferase activity in human erythrocyte by LC-MS/MS
    Mei, Shenghui
    Li, Xindi
    Gong, Xiaoqing
    Zhang, Xiaoyi
    Li, Xingang
    Yang, Li
    Zhu, Leting
    Zhou, Heng
    Liu, Yonghong
    Zhou, Anna
    Zhang, Xinghu
    Zhao, Zhigang
    BIOMEDICAL CHROMATOGRAPHY, 2017, 31 (09)
  • [45] Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity
    Mette Levinsen
    Susanne Rosthøj
    Ulrikka Nygaard
    Jesper Heldrup
    Arja Harila-Saari
    Olafur G. Jonsson
    Anne Grete Bechensteen
    Jonas Abrahamsson
    Birgitte Lausen
    Thomas L. Frandsen
    Richard M. Weinshilboum
    Kjeld Schmiegelow
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 59 - 66
  • [46] Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity
    Levinsen, Mette
    Rosthoj, Susanne
    Nygaard, Ulrikka
    Heldrup, Jesper
    Harila-Saari, Arja
    Jonsson, Olafur G.
    Bechensteen, Anne Grete
    Abrahamsson, Jonas
    Lausen, Birgitte
    Frandsen, Thomas L.
    Weinshilboum, Richard M.
    Schmiegelow, Kjeld
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (01) : 59 - 66
  • [47] Methylation of 6-mercaptopurine and 6-thioguanine by thiopurine S-methyltransferase -: A comparison of activity in red blood cell samples of 199 blood donors
    Kröplin, T
    Iven, H
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (04) : 343 - 345
  • [48] Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatment
    van Asseldonk, Dirk P.
    Seinen, Margien L.
    de Boer, Nanne K. H.
    van Bodegraven, Ad A.
    Mulder, Chris J.
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (01): : 95 - 101
  • [49] Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy
    Dervieux, T
    Meyer, G
    Barham, R
    Matsutani, M
    Barry, M
    Boulieu, R
    Neri, B
    Seidman, E
    CLINICAL CHEMISTRY, 2005, 51 (11) : 2074 - 2084
  • [50] Comments on "High-performance liquid chromatographic determination of methyl 6-mercaptopurine nucleotides in red blood cells". Reply
    Mawatari, H
    Kato, Y
    Nishimura, S
    Sakura, N
    Ueda, K
    JOURNAL OF CHROMATOGRAPHY B, 1999, 730 (02): : 275 - 276
12345